SEC Comment Letter for Nuo Therapeutics, Inc. (AURX) (CIK 0001091596) (AURX) — Oct 2, 2007

Nuo Therapeutics, Inc. (AURX) (CIK 0001091596)
Date: Oct. 2, 2007 · CIK: 0001091596 · Accession: 0000000000-07-048002

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-32518

Date

October 2, 2007

Author

Not clearly detected

Form

UPLOAD

Company

Nuo Therapeutics, Inc. (AURX) (CIK 0001091596)

Letter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 DIVISION OF CORPORATION FINANCE Mail Stop 6010 October 2, 2007 VIA U.S. MAIL and FACSIMILE Andrew S. Maslan Cytomedix, Inc. Chief Financial Officer 416 Hungerford Drive, Suite 330 Rockville, MD 20850 RE: Cytomedix, Inc. Form 10-K for the fiscal year ended December 31, 2006 Filed February 26, 2007 File No. 001-32518

Dear Mr. Maslan: We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments. S i n c e r e l y , M a r t i n F . J a m e s Senior Assistant Chief Accountant

Show Raw Text

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

       DIVISION OF
CORPORATION FINANCE

Mail Stop 6010

 October 2, 2007

VIA U.S. MAIL and FACSIMILE

  Andrew S. Maslan Cytomedix, Inc.  Chief Financial Officer 416 Hungerford Drive, Suite 330 Rockville, MD  20850
 RE: Cytomedix, Inc.
  Form 10-K for the fiscal year ended December 31, 2006
  Filed February 26, 2007   File No. 001-32518

Dear Mr. Maslan:   We have completed our review of your Form  10-K and related filings and do not, at this
time, have any further comments.            S i n c e r e l y ,            M a r t i n  F .  J a m e s         Senior Assistant Chief Accountant

SecProbe.io